Home Core Services Funding Opportunities Research Membership Publications and Resources Contact

Meetings

Hepatitis C Virus: The Changing Paradigm
Wednesday, April 27, 2011
Providence, RI  

CDAAR’s Hepatitis and Liver Function Core hosted a one-day symposium titled “Hepatitis C Virus: The Changing Paradigm” on April 27, 2011 in Providence, Rhode Island. Drs. Knox and Taylor planned this symposium with the support of Dr. Mehta to bring together experts in HCV treatment and research. This comprehensive conference was well received and approximately 180 healthcare professionals from around New England attended. The audience size was limited by the conference center regulations and the conference had a long waiting list for places. This symposium was instrumental in carrying out some of the primary goals of the Core, which are to increase awareness of HCV infection, identify populations at risk, review current and new treatment methods, and consider other issues impacting care such as the cost of treatment and co-morbidities (including HIV infection, alcohol and substance misuse, psychiatric issues, and nutritional deficiencies). This symposium targeted physicians, nurses, public health officials, social workers, and research coordinators in the fields of HIV, infectious disease, gastroenterology, and corrections.

The CDAAR planning committee for the Liver Symposium planned this event with the hopes of not only providing education, but helping to identify further areas of research and foster collaboration amongst CDAAR members.

The program outline, presentation slides, and objectives are available below:

Program Outline

References

Tamsin Knox MD, MPH, Associate Professor, Tufts University School of Medicine, giving the welcome and introduction to the Liver Symposium
Tamsin Knox MD, MPH, Associate Professor, Tufts University School of Medicine, giving the welcome and introduction to the Liver Symposium

Presenter

Session and Objectives

Presentation Slides

 Kenneth Mayer, MD

Professor of Medicine and Community Health
Warren Alpert Medical School of Brown University
Director, Brown AIDS Program
The Miriam Hospital
Providence, RI

 “Acute HCV”

Educational Objectives :

  • Describe how HCV is transmitted
  • Recognize signs and symptoms of acute HCV
  • Explain how to protect against HCV

View Slides (PDF)

 Lynn Taylor, MD, AAHIVS

Assistant Professor of Medicine
Warren Alpert Medical School of
Brown University
Providence, RI

 

 “Genetic Determinants in HCV”

Educational Objectives :

  • Understand key recent advances in genomics and Hepatitis C Virus
  • Describe the biological importance of IL28B genotypes
  • Understand the clinical relevance of genetic variation in IL28B

 

View Slides (PDF)

 Arthur Kim, MD

Assistant Professor of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic (Infectious Diseases)
Massachusetts General Hospital
Boston, MA

 “HCV Screening & Treatment Guidelines”

Educational Objectives:

  • Identify who is at risk for acute and chronic HCV infection (to guide screening practices
  • Determine which HCV-infected patients are candidates for treatment

View Slides (PDF)

 Shruti Mehta, PhD

Associate Professor of
Epidemiology
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD

 “Assessment of Liver Fibrosis”

Educational Objectives:

  • Characterize methods of ascertaining liver fibrosis
  • Define the benefits and drawbacks of invasive and noninvasive methods for ascertaining liver fibrosis
  • Summarize methodologic challenges for ascertainment of liver fibrosis

View Slides (PDF)

 Raymond Chung, MD

Associate Professor of Medicine
Harvard Medical School
Director of Hepatology, Vice Chief of Gastroenterology
Massachusetts General Hospital
Boston, MA

 “New HCV Medications”

Educational Objectives:

  • Discuss the new treatment options for HCV
  • Explain the antiviral targets for HCV agents
  • Recognize the limitations of direct acting antiviral therapy

View Slides (PDF)

Shruti Mehta, PhD

Associate Professor of Epidemiology
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD

“Why we Fail to Treat HCV”

Educational Objectives:

  • Characterize population level-effectiveness of HCV treatment among IDUs
  • Identify the barriers to receiving treatment for HCV infection among IDUs
  • Determine strategies to overcome barriers to HCV treatment among IDUs

View Slides (PDF)

Scott Holmberg, MD, MPH

Chief, Epidemiology and Surveillance Branch Division of Viral Hepatitis, NCHHSTP
Centers for Disease Control and Prevention
Atlanta, GA

“Public Health Issues in HCV: Primary and Secondary Prevention”

Educational Objectives:

  • Identify major modes of HCV transmission in the United States
  • Describe prevalence, morbidity and mortality of HCV in the United States
  • Indicate major barriers to the testing, linkage to care and treatment of chronic HCV patients in the United States

View Slides (PDF)

 Josiah Rich, MD, MPH

Professor of Medicine and Community Health
Warren Alpert Medical School of Brown University
Director & Co-founder, The Center for Prisoner Health and Human Rights
The Miriam Hospital
Providence, RI

 “HCV in Corrections”

Educational Objectives:

  • Describe the magnitude of HCV infection in incarcerated populations
  • Identify the epidemiology of incarceration in the US
  • Recognize the opportunities for HCV diagnosis, treatment and prevention in correctional populations

View Slides (PDF)

John Wong, MD

Professor of Medicine
Tufts University School of Medicine
Chief, Division of Clinical Decision Making, Informatics, and Telemedicine
Department of Medicine
Tufts Medical Center
Boston, MA

 “The Cost of HCV Care”

Educational Objectives:

  • Identify cost components for the care and treatment of chronic HCV infection
  • Discuss the economic implications and impact of the new direct acting agents for HCV
  • Describe the economics of treating HCV in populations such as prisoners, and underinsured persons

View Slides (PDF)

 Barbara McGovern, MD

Associate Professor of Medicine
Tufts University School of Medicine
Division of Infectious Diseases
Lemuel Shattuck Hospital
Boston, MA

 “A New Dawn for HIV/HCV Coinfected Patients”

Educational Objectives:

  • Define the major issues that have thwarted viral clearance in HIV/HCV coinfected patients
  • Describe the metabolic complications of HCV coinfection
  • Understand the role HIV infection itself may be playing in liver disease

View Slides (PDF)

Lorenzo Leggio, MD, MSc

Assistant Professor of Community Health (Research)
Warren Alpert Medical School of Brown University
Center for Alcohol and Addiction Studies
Providence, RI

 “HCV and Alcohol”

Educational Objectives:

  • Define alcohol use disorders (AUDs) and alcohol-related medical problems
  • Illustrate comorbidity between AUDs and HCV
  • Illustrate medical interventions for patients with AUDs, including those with AUDS and HCV

View Slides (PDF)

 Christine Wanke, MD

Professor and Associate Chair, Department of Medicine and Public Health and Community Medicine
Tufts University School of Medicine
Boston, MA

 “Nutrition and HCV’

Educational Objectives:

  • Describe interactions between nutrition and HCV
  • Identify nutritional complications of HCV
  • Recognize implications of nutritional complications of HCV

View Slides (PDF)

Glenn Treisman, MD, PhD

Professor of Psychiatry and Behavioral Sciences
Professor of Internal Medicine
Director of AIDS Psychiatry Services
Johns Hopkins School of Medicine
Baltimore, MD

“HCV and Psychiatry”

Educational Objectives:

  • Describe the relationship between Hepatitis C and depression
  • Discuss the issues of treating addiction in patients with Hepatitis C
  • List the features of personality disorder in patients with Hepatitis C

View Slides (PDF)

Home Core Services Funding Opportunities Research Membership Publications and Resources Contact